(Q31913380)

5 July 2017

Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: amelioration by radical scavengers (English)

1 reference

5 July 2017

0 references

Iyamu EW

1

1 reference

5 July 2017

Fasold H

2

1 reference

5 July 2017

Roa D

3

1 reference

5 July 2017

del Pilar Aguinaga M

4

1 reference

5 July 2017

Asakura T

5

1 reference

5 July 2017

Turner EA

6

1 reference

5 July 2017

1 January 2001

1 reference

Journal of Clinical Laboratory Analysis

5 July 2017

1 reference

5 July 2017

15

1 reference

5 July 2017

1

1 reference

5 July 2017

1-7

1 reference

Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia

5 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Spontaneous oxygen radical generation by sickle erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Role of Haemichromes in the Formation of Inclusion Bodies in Haemoglobin H Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by Hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Hydroxyurea therapy in children severely affected with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Protection against hydroxyurea-induced cytotoxic effects in L5178Y cells by free radical scavengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Hydroxyurea has the capacity to induce damage to human erythrocytes which can be modified by radical scavengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

The Structure of a Hemoglobin Carrying Only Two Hemes*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

Heme stability in the human embryonic hemoglobins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2825%282001%2915%3A1%3C1%3A%3AAID-JCLA1%3E3.0.CO%3B2-I

10.1002/1098-2825(2001)15:1<1::AID-JCLA1>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference